A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern

被引：17

作者：

Lan, Qiaoshuai ^{[1
]}

Chan, Jasper Fuk-Woo ^{[2
,3
,4
]}

Xu, Wei ^{[1
]}

Wang, Lijue ^{[1
]}

Jiao, Fanke ^{[1
]}

Zhang, Guangxu ^{[1
]}

Pu, Jing ^{[1
]}

Zhou, Jie ^{[1
]}

Xia, Shuai ^{[1
]}

Lu, Lu ^{[1
]}

Yuen, Kwok-Yung ^{[2
,3
,4
]}

Jiang, Shibo ^{[1
]}

Wang, Qian ^{[1
]}

机构：

[1] Fudan Univ, Shanghai Frontiers Sci Ctr Pathogen Microbes & In, Sch Basic Med Sci, Shanghai Inst Infect Dis & Biosecur,Key Lab Med M, Shanghai 200032, Peoples R China

[2] Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect,Pokfulam, Dept Microbiol,State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China

[3] Univ Hong Kong, Dept Clin Microbiol & Infect Control, Shenzhen Hosp, Shenzhen 518000, Peoples R China

[4] Hong Kong Sci & Technol Pk, Ctr Virol Vaccinol & Therapeut, Hong Kong, Peoples R China

来源：

VIRUSES-BASEL | 2022年 / 14卷 / 03期

基金：

中国国家自然科学基金;

关键词：

palmitic acid; lipopeptide; Omicron; beta-coronavirus; entry inhibitor; SPIKE PROTEIN; CORONAVIRUS; SARS; ANTIBODIES; VACCINE;

D O I：

10.3390/v14030549

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Our previous studies have shown that cholesterol-conjugated, peptide-based pan-coronavirus (CoV) fusion inhibitors can potently inhibit human CoV infection. However, only palmitic acid (C16)-based lipopeptide drugs have been tested clinically, suggesting that the development of C16based lipopeptide drugs is feasible. Here, we designed and synthesized a C16-modified pan-CoV fusion inhibitor, EK1-C16, and found that it potently inhibited infection by SARS-CoV-2 and its variants of concern (VOCs), including Omicron, and other human CoVs and bat SARS-related CoVs (SARSr-CoVs). These results suggest that EK1-C16 could be further developed for clinical use to prevent and treat infection by the currently circulating MERS-CoV, SARS-CoV-2 and its VOCs, as well as any future emerging or re-emerging coronaviruses.

引用

页数：11

共 50 条

[1] Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
Xia, Shuai
Chan, Jasper Fuk-Woo
Wang, Lijue
Jiao, Fanke
Chik, Kenn Ka-Heng
Chu, Hin
Lan, Qiaoshuai
Xu, Wei
Wang, Qian
Wang, Chao
Yuen, Kwok-Yung
Lu, Lu
Jiang, Shibo
CELL RESEARCH, 2022, 32 (04) : 404 - 406
[2] Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
Shuai Xia
Jasper Fuk-Woo Chan
Lijue Wang
Fanke Jiao
Kenn Ka-Heng Chik
Hin Chu
Qiaoshuai Lan
Wei Xu
Qian Wang
Chao Wang
Kwok-Yung Yuen
Lu Lu
Shibo Jiang
Cell Research, 2022, 32 : 404 - 406
[3] SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
Xia, Shuai
Wang, Lijue
Jiao, Fanke
Yu, Xueying
Xu, Wei
Huang, Ziqi
Li, Xicheng
Wang, Qian
Zhu, Yun
Man, Qiuhong
Jiang, Shibo
Lu, Lu
EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
[4] Evaluation of Potential Peptide-Based Inhibitors against SARS-CoV-2 and Variants of Concern
Boshah, Hattan
Samkari, Faris
Valle-Perez, Alexander U.
Alsawaf, Sarah M.
Aldoukhi, Ali H.
Bilalis, Panayiotis
Alshehri, Salwa A.
Susapto, Hepi H.
Hauser, Charlotte A. E.
BIOMED RESEARCH INTERNATIONAL, 2023, 2023
[5] Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation
Xia, Shuai
Lan, Qiaoshuai
Zhu, Yun
Wang, Chao
Xu, Wei
Li, Yutang
Wang, Lijue
Jiao, Fanke
Zhou, Jie
Hua, Chen
Wang, Qian
Cai, Xia
Wu, Yang
Gao, Jie
Liu, Huan
Sun, Ge
Muench, Jan
Kirchhoff, Frank
Yuan, Zhenghong
Xie, Youhua
Sun, Fei
Jiang, Shibo
Lu, Lu
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
[6] A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
Yuan, Mengqi
Chen, Xiangyu
Zhu, Yanzhi
Dong, Xiaoqing
Liu, Yan
Qian, Zhaohui
Ye, Lilin
Liu, Pinghuang
JOURNAL OF VIROLOGY, 2022, 96 (16)
[7] Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation
Shuai Xia
Qiaoshuai Lan
Yun Zhu
Chao Wang
Wei Xu
Yutang Li
Lijue Wang
Fanke Jiao
Jie Zhou
Chen Hua
Qian Wang
Xia Cai
Yang Wu
Jie Gao
Huan Liu
Ge Sun
Jan Münch
Frank Kirchhoff
Zhenghong Yuan
Youhua Xie
Fei Sun
Shibo Jiang
Lu Lu
Signal Transduction and Targeted Therapy, 6
[8] SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection
Zannella, Carla
Chianese, Annalisa
Monti, Alessandra
Giugliano, Rosa
Morone, Maria Vittoria
Secci, Francesco
Sanna, Giuseppina
Manzin, Aldo
De Filippis, Anna
Doti, Nunzianna
Galdiero, Massimiliano
PHARMACEUTICS, 2023, 15 (12)
[9] A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
Hanjun Zhao
Kelvin Kai-Wang To
Hoiyan Lam
Chuyuan Zhang
Zheng Peng
Xinjie Meng
Xiankun Wang
Anna Jinxia Zhang
Bingpeng Yan
Jianpiao Cai
Man Lung Yeung
Jasper Fuk-Woo Chan
Kwok-Yung Yuen
Cell Discovery, 8
[10] A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
Zhao, Hanjun
To, Kelvin Kai-Wang
Lam, Hoiyan
Zhang, Chuyuan
Peng, Zheng
Meng, Xinjie
Wang, Xiankun
Zhang, Anna Jinxia
Yan, Bingpeng
Cai, Jianpiao
Yeung, Man Lung
Chan, Jasper Fuk-Woo
Yuen, Kwok-Yung
CELL DISCOVERY, 2022, 8 (01)

← 1 2 3 4 5 →